In depth understanding of adverse ventricular remodeling after acute myocardial infarction

Affiliations

¹ Department of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria; Department of Cardiology, REHA Zentrum Muenster, Tyrol, Austria. Electronic address: mail@med.cbrenner.net.

Comment

Christoph Brenner. Int J Cardiol. 2018.

. 2018 Apr 15:257:34.

doi: 10.1016/j.ijcard.2017.12.080.

¹ Department of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria; Department of Cardiology, REHA Zentrum Muenster, Tyrol, Austria. Electronic address: mail@med.cbrenner.net.

No abstract available

Comment on

Diagnostic and prognostic value of miR-1 and miR-29b on adverse ventricular remodeling after acute myocardial infarction - The SITAGRAMI-miR analysis.
Grabmaier U, Clauss S, Gross L, Klier I, Franz WM, Steinbeck G, Wakili R, Theiss HD, Brenner C. Grabmaier U, et al. Int J Cardiol. 2017 Oct 1;244:30-36. doi: 10.1016/j.ijcard.2017.06.054. Epub 2017 Jun 19. Int J Cardiol. 2017. PMID: 28663047 Clinical Trial.
Pathogenic effect of PI3K/Akt signaling inhibition by miR-1 and miR-29b on adverse post-infarct ventricular remodeling.
Wu Y, Wang T, Sun X. Wu Y, et al. Int J Cardiol. 2018 Apr 15;257:275. doi: 10.1016/j.ijcard.2017.12.031. Int J Cardiol. 2018. PMID: 29506707 No abstract available.